Stockreport

Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference

Revolution Medicines, Inc.  (RVMD) 
PDF REDWOOD CITY, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies [Read more]